Artisan Partners Limited Partnership Madrigal Pharmaceuticals, Inc. Transaction History

Artisan Partners Limited Partnership

$58.2 Billion
Q1 2025

A detailed history of Artisan Partners Limited Partnership transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 137,738 shares of MDGL stock, worth $58.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

137,738

Previous 207,469 33.61%

Holding current value

$58.6 Million

Previous $64 Million 28.74%

% of portfolio

0.08%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$272.79 - $355.88 $19 Million - $24.8 Million	-69,731 Reduced 33.61%	137,738 $45.6 Million
Q4 2024 Feb 12, 2025	SELL	$202.45 - $354.85 $20.1 Million - $35.3 Million	-99,377 Reduced 32.39%	207,469 $64 Million
Q3 2024 Nov 12, 2024	SELL	$212.22 - $292.96 $8.12 Million - $11.2 Million	-38,239 Reduced 11.08%	306,846 $65.1 Million
Q2 2024 Aug 12, 2024	SELL	$193.33 - $291.99 $10.9 Million - $16.5 Million	-56,624 Reduced 14.1%	345,085 $96.7 Million
Q1 2024 May 13, 2024	BUY	$171.37 - $283.23 $18 Million - $29.8 Million	105,229 Added 35.49%	401,709 $107 Million
Q4 2023 Feb 12, 2024	BUY	$120.4 - $237.13 $1.97 Million - $3.89 Million	16,390 Added 5.85%	296,480 $68.6 Million
Q3 2023 Nov 09, 2023	BUY	$146.04 - $225.78 $7.3 Million - $11.3 Million	50,000 Added 21.73%	280,090 $40.9 Million
Q2 2023 Aug 10, 2023	BUY	$203.88 - $312.0 $2.92 Million - $4.47 Million	14,320 Added 6.64%	230,090 $53.2 Million
Q1 2023 May 11, 2023	BUY	$231.06 - $307.08 $804,088 - $1.07 Million	3,480 Added 1.64%	215,770 $52.3 Million
Q4 2022 Feb 10, 2023	BUY	$58.39 - $296.54 $105,569 - $536,144	1,808 Added 0.86%	212,290 $61.6 Million
Q3 2022 Nov 10, 2022	SELL	$60.57 - $79.51 $74,925 - $98,353	-1,237 Reduced 0.58%	210,482 $13.7 Million
Q2 2022 Aug 12, 2022	SELL	$58.04 - $100.2 $702,109 - $1.21 Million	-12,097 Reduced 5.4%	211,719 $15.2 Million
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $219,759 - $400,631	3,932 Added 1.79%	223,816 $22 Million
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $72,701 - $95,565	-1,005 Reduced 0.45%	219,884 $18.6 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $15,826 - $21,214	202 Added 0.09%	220,889 $17.6 Million
Q2 2021 Aug 12, 2021	BUY	$97.2 - $137.59 $608,666 - $861,588	6,262 Added 2.92%	220,687 $21.5 Million
Q1 2021 May 11, 2021	BUY	$108.54 - $125.2 $439,044 - $506,434	4,045 Added 1.92%	214,425 $25.1 Million
Q4 2020 Feb 10, 2021	BUY	$110.06 - $133.7 $4.09 Million - $4.96 Million	37,120 Added 21.42%	210,380 $23.4 Million
Q3 2020 Nov 12, 2020	BUY	$99.78 - $124.21 $17.3 Million - $21.5 Million	173,260 New	173,260 $20.6 Million

Others Institutions Holding MDGL

# of Institutions

355

Shares Held

23.2M

Call Options Held

738K

Put Options Held

473K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $7.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.

Account

Artisan Partners Limited Partnership Madrigal Pharmaceuticals, Inc. Transaction History